126 related articles for article (PubMed ID: 33493787)
1. Effects of
Tago T; Toyohara J; Fujimaki R; Tatsuta M; Song R; Hirano K; Iwai K; Tanaka H
Nucl Med Biol; 2021; 94-95():38-45. PubMed ID: 33493787
[TBL] [Abstract][Full Text] [Related]
2. F-18 Polyethyleneglycol stilbenes as PET imaging agents targeting Abeta aggregates in the brain.
Zhang W; Oya S; Kung MP; Hou C; Maier DL; Kung HF
Nucl Med Biol; 2005 Nov; 32(8):799-809. PubMed ID: 16253804
[TBL] [Abstract][Full Text] [Related]
3. F-18 stilbenes as PET imaging agents for detecting beta-amyloid plaques in the brain.
Zhang W; Oya S; Kung MP; Hou C; Maier DL; Kung HF
J Med Chem; 2005 Sep; 48(19):5980-8. PubMed ID: 16162001
[TBL] [Abstract][Full Text] [Related]
4. Characterization of AZD4694, a novel fluorinated Abeta plaque neuroimaging PET radioligand.
Juréus A; Swahn BM; Sandell J; Jeppsson F; Johnson AE; Johnström P; Neelissen JA; Sunnemark D; Farde L; Svensson SP
J Neurochem; 2010 Aug; 114(3):784-94. PubMed ID: 20477945
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of two 18F-labeled 6-iodo-2-(4'-N,N-dimethylamino)phenylimidazo[1,2-a]pyridine derivatives as prospective radioligands for beta-amyloid in Alzheimer's disease.
Cai L; Chin FT; Pike VW; Toyama H; Liow JS; Zoghbi SS; Modell K; Briard E; Shetty HU; Sinclair K; Donohue S; Tipre D; Kung MP; Dagostin C; Widdowson DA; Green M; Gao W; Herman MM; Ichise M; Innis RB
J Med Chem; 2004 Apr; 47(9):2208-18. PubMed ID: 15084119
[TBL] [Abstract][Full Text] [Related]
6. Preclinical characterization of a novel class of 18F-labeled PET tracers for amyloid-β.
Brockschnieder D; Schmitt-Willich H; Heinrich T; Varrone A; Gulyás B; Toth M; Andersson J; Boemer U; Krause S; Friebe M; Dinkelborg L; Halldin C; Dyrks T
J Nucl Med; 2012 Nov; 53(11):1794-801. PubMed ID: 23008501
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of a (18)F-curcumin derivate for β-amyloid plaque imaging.
Rokka J; Snellman A; Zona C; La Ferla B; Nicotra F; Salmona M; Forloni G; Haaparanta-Solin M; Rinne JO; Solin O
Bioorg Med Chem; 2014 May; 22(9):2753-62. PubMed ID: 24702859
[TBL] [Abstract][Full Text] [Related]
8. Preclinical evaluation of [
Zha Z; Ploessl K; Choi SR; Alexoff D; Kung HF
Nucl Med Biol; 2021 Jan; 92():97-106. PubMed ID: 32245565
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of novel ¹⁸F labeled 2-pyridinylbenzoxazole and 2-pyridinylbenzothiazole derivatives as ligands for positron emission tomography (PET) imaging of β-amyloid plaques.
Cui M; Wang X; Yu P; Zhang J; Li Z; Zhang X; Yang Y; Ono M; Jia H; Saji H; Liu B
J Med Chem; 2012 Nov; 55(21):9283-96. PubMed ID: 22974116
[TBL] [Abstract][Full Text] [Related]
10. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
11. Validation of an (18)F-labeled biphenylalkyne as a positron emission tomography imaging agent for beta-amyloid plaques.
Wey SP; Weng CC; Lin KJ; Yao CH; Yen TC; Kung HF; Skovronsky D; Kung MP
Nucl Med Biol; 2009 May; 36(4):411-7. PubMed ID: 19423009
[TBL] [Abstract][Full Text] [Related]
12. A 18F-labeled BF-227 derivative as a potential radioligand for imaging dense amyloid plaques by positron emission tomography.
Furumoto S; Okamura N; Furukawa K; Tashiro M; Ishikawa Y; Sugi K; Tomita N; Waragai M; Harada R; Tago T; Iwata R; Yanai K; Arai H; Kudo Y
Mol Imaging Biol; 2013 Aug; 15(4):497-506. PubMed ID: 23362000
[TBL] [Abstract][Full Text] [Related]
13. Neopentyl Glycol as a Scaffold to Provide Radiohalogenated Theranostic Pairs of High
Suzuki H; Kaizuka Y; Tatsuta M; Tanaka H; Washiya N; Shirakami Y; Ooe K; Toyoshima A; Watabe T; Teramoto T; Sasaki I; Watanabe S; Ishioka NS; Hatazawa J; Uehara T; Arano Y
J Med Chem; 2021 Nov; 64(21):15846-15857. PubMed ID: 34708646
[TBL] [Abstract][Full Text] [Related]
14. Impact of partial volume effect correction on cerebral β-amyloid imaging in APP-Swe mice using [(18)F]-florbetaben PET.
Brendel M; Delker A; Rötzer C; Böning G; Carlsen J; Cyran C; Mille E; Gildehaus FJ; Cumming P; Baumann K; Steiner H; Haass C; Herms J; Bartenstein P; Rominger A
Neuroimage; 2014 Jan; 84():843-53. PubMed ID: 24055703
[TBL] [Abstract][Full Text] [Related]
15. (18)F-Labeled benzylideneaniline derivatives as new ligands for beta-amyloid plaque imaging in Alzheimer's disease.
Lee HJ; Jeong JM; Rai G; Lee YS; Chang YS; Kim YJ; Kim HW; Lee DS; Chung JK; Mook-Jung I; Lee MC
Nucl Med Biol; 2009 Feb; 36(2):107-16. PubMed ID: 19217522
[TBL] [Abstract][Full Text] [Related]
16. Conversion of iodine to fluorine-18 based on iodinated chalcone and evaluation for β-amyloid PET imaging.
Kaide S; Ono M; Watanabe H; Shimizu Y; Nakamoto Y; Togashi K; Yamaguchi A; Hanaoka H; Saji H
Bioorg Med Chem; 2018 Jul; 26(12):3352-3358. PubMed ID: 29751990
[TBL] [Abstract][Full Text] [Related]
17. Fluoro-pegylated chalcones as positron emission tomography probes for in vivo imaging of beta-amyloid plaques in Alzheimer's disease.
Ono M; Watanabe R; Kawashima H; Cheng Y; Kimura H; Watanabe H; Haratake M; Saji H; Nakayama M
J Med Chem; 2009 Oct; 52(20):6394-401. PubMed ID: 19757822
[TBL] [Abstract][Full Text] [Related]
18.
Li Z; Zhang X; Zhang X; Cui M; Lu J; Pan X; Zhang X
J Med Chem; 2016 Dec; 59(23):10577-10585. PubMed ID: 27933958
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and Evaluation of Fluorine-18 Labeled 2-Phenylquinoxaline Derivatives as Potential Tau Imaging Agents.
Zhou K; Yang F; Li Y; Chen Y; Zhang X; Zhang J; Wang J; Dai J; Cai L; Cui M
Mol Pharm; 2021 Mar; 18(3):1176-1195. PubMed ID: 33475377
[TBL] [Abstract][Full Text] [Related]
20. Fluorine-18 radiolabeled heterocycles as PET tracers for imaging β-amyloid plaques in Alzheimer's disease.
Zeng F; Goodman MM
Curr Top Med Chem; 2013; 13(8):909-19. PubMed ID: 23590167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
